McKesson Corporation (NYSE:MCK) today announced that Mark Walchirk has been promoted to president, McKesson Specialty Care Solutions, effective immediately. Walchirk will report to Paul Julian, executive vice president and group president, McKesson Corporation. He will have overall responsibility for the McKesson Specialty Care Solutions business unit, which delivers services to pharmaceutical and biotech manufacturers and specialty providers, including oncologists to ensure specialty pharmaceutical products, coordinated reimbursement and clinical services are available to patients with complex diseases. Walchirk replaces Patrick Blake, who was promoted in June 2009 to executive vice president and group president, McKesson Corporation, with overall responsibility for McKesson`s Technology Solutions segment.
"McKesson sees tremendous opportunity in the specialty and biotech marketplace to help our customers achieve greater business and clinical success while accelerating our own growth," said Paul Julian. "Mark`s deep and broad sales and operational experience in healthcare, strong leadership skills, and proven track record of delivering results, make him ideally suited to lead McKesson Specialty Care Solutions and help McKesson continue building momentum in the fast-growing specialty market. We see this promotion as another testament to McKesson`s deep bench of talented senior leaders and a point of pride to be able to once again promote from within."
McKesson Specialty Care Solutions is the second largest distributor of specialty pharmaceuticals and biologics and the largest distributor of rheumatology drugs in the United States. In addition, this McKesson business is the centralized distributor for the Centers for Disease Control & Prevention`s (CDC) public-sector purchased adult and pediatric vaccines, including the 2009 H1N1 vaccine and those distributed under the CDC`s Vaccines for Children program.
Most recently, Walchirk served as senior vice president and chief operating officer, McKesson U.S. Pharmaceutical. In that role, Walchirk had responsibility for McKesson`s U.S. Pharmaceutical sales, distribution and customer service operations in the United States. During his tenure, Walchirk led McKesson`s acquisition of two leading regional pharmaceutical distributors, D&K Healthcare and McQueary Brothers Drug Company, helped drive the growth of McKesson`s Health Mart franchise from 250 to 2,300 stores, led the expansion of McKesson`s pharmaceutical distribution business in the institutional market, and guided McKesson to industry-leading levels of accuracy and efficiency across its distribution operations. Walchirk joined McKesson in 2001 as senior vice president, national accounts.
Walchirk`s entire career has been in healthcare. Before joining McKesson, he spent 13 years in medical-surgical distribution and manufacturing with Baxter Healthcare, Allegiance Healthcare and Encompass Group, holding various leadership positions in sales, marketing, operations and business development. Walchirk earned his B.S. in Business Administration from the University of Illinois.
No comments:
Post a Comment